The two faces of the inflammasome adaptor ASC in epithelial skin carcinogenesis

Clinical and Experimental Rheumatology

Volumn 33, Issue , 2015, Pages 94-96

  Yazdi, Amir S ^a   Drexler, Stefan K ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Carcinogenesis; IL 1; Inflammasome

Indexed keywords

ADAPTOR PROTEIN; ASC PROTEIN; INFLAMMASOME; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; CYTOSKELETON PROTEIN; PYCARD PROTEIN, HUMAN; PYCARD PROTEIN, MOUSE;

ARTICLE; CANCER GROWTH; COLITIS; CORRELATIONAL STUDY; ENTEROPATHY; HUMAN; INTESTINE EPITHELIUM; PRIORITY JOURNAL; PROTEIN ACTIVATION; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SKIN CARCINOGENESIS; SKIN EPITHELIUM; ANIMAL; CELL TRANSFORMATION; COLON TUMOR; EPITHELIUM CELL; IMMUNOLOGY; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; SKIN; SKIN TUMOR;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; CYTOSKELETAL PROTEINS; EPITHELIAL CELLS; HUMANS; INFLAMMASOMES; SIGNAL TRANSDUCTION; SKIN; SKIN NEOPLASMS;

EID: 84953342756     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. LATZ E, XIAO TS, STUTZ A: Activation and regulation of the inflammasomes. Nat Rev Immunol 2013; 13: 397-411.
2. YAZDI AS, DREXLER SK, TSCHOPP J: The role of the inflammasome in nonmyeloid cells. J Clin Immunol 2010; 30: 623-7.
3. SO A, De SMEDT T, REVAZ S et al.: A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res Ther 2007; 9: R28.
4. KUEMMERLE-DESCHNER JB, LOHSE P, KOETTER I et al.: NLRP3 E311K mutation in a large family with Muckle-Wells syndromedescription of a heterogeneous phenotype and response to treatment. Arthritis Res Ther 2011; 13: R196.
5. MARTINON F, PéTRILLI V, MAYOR A et al.: Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006; 440: 237.41.
6. HANAHAN D, WEINBERG RA: Hallmarks of cancer: the next generation. Cell 2011; 144: 646-74.
7. TU S, BHAGAT G, CUI G et al.: Overexpression of Interleukin-1β Induces Gastric Inflammation and Cancer and Mobilizes Myeloid-Derived Suppressor Cells in Mice. Cancer Cell 2008; 14: 408-19.
8. REED JR, LEON RP, HALL MK et al.: Interleukin-1beta and fibroblast growth factor receptor 1 cooperate to induce cyclooxygenase-2 during early mammary tumourigenesis. Breast Cancer Res 2009; 11: R21.
9. KRELIN Y, VORONOV E, DOTAN S et al.: Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors. Cancer Res 2007; 67: 1062-71.
10. ELKABETS M, RIBEIRO VSG, DINARELLO CA et al.: IL-1β regulates a novel myeloidderived suppressor cell subset that impairs NK cell development and function. Eur J Immunol 2010; 40: 3347-57.
11. HUBER S, GAGLIANI N, ZENEWICZ LA et al.: IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature 2012; 491: 259-63.
12. SALCEDO R, WORSCHECH A, CARDONE M et al.: MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18. J Exp Med 2010; 207: 1625-36.
13. DUPAUL-CHICOINE J, YERETSSIAN G, DOIRON K et al.: Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity 2010; 32: 367-78.
14. ZAKI MH, VOGEL P, BODY-MALAPEL M et al.: IL-18 Production downstream of the nlrp3 inflammasome confers protection against colorectal tumor formation. J Immunol 2010; 185: 4912-20.
15. PIZARRO TT, MICHIE MH, BENTZ M et al.: IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. J Immunol 1999; 162: 6829-35.
16. ALLEN IC, TeKIPPE EM, WOODFORD R-MT et al.: The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J Exp Med 2010; 207: 1045-56.
17. HU B, ELINAV E, HUBER S et al.: Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4. Proc Natl Acad Sci USA 2010; 107 21635-40.
18. ELINAV E, STROWIG T, KAU AL et al.: NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011; 145: 745-57.
19. CONTASSOT E, BEER H, FRENCH L: Interleukin-1, inflammasomes, autoinflammation and the skin. Swiss Medical Weekly Published Online First: 31 May 2012.
20. FELDMEYER L, KELLER M, NIKLAUS G et al.: The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes. Curr Biol 2007; 17: 1140-5.
21. CHOW MT, TSCHOPP J, MöLLER A et al.: NLRP3 promotes inflammation-induced skin cancer but is dispensable for asbestos-induced mesothelioma. Immunol Cell Biol 2012; 90: 983-6.
22. GUARDA G, ZENGER M, YAZDI AS et al.: Differential expression of NLRP3 among hematopoietic cells. J Immunol 2011; 186: 2529-34.
23. DREXLER SK, BONSIGNORE L, MASIN M et al.: Tissue-specific opposing functions of the inflammasome adaptor ASC in the regulation of epithelial skin carcinogenesis. Proc Natl Acad Sci USA 2012; 109: 18384-9. Epub 2012 Oct 22.
24. STIMSON KM, VERTINO PM: Methylationmediated silencing of TMS1/ASC is accompanied by histone hypoacetylation and CpG island-localized changes in chromatin architecture. J Biol Chem 2002; 277: 4951-8.
25. LEVINE JJ, STIMSON-CRIDER KM, VERTINO PM: Effects of methylation on expression of TMS1/ASC in human breast cancer cells. Oncogene 2003; 22: 3475-88.
26. GUAN X, SAGARA J, YOKOYAMA T et al.: ASC/TMS1, a caspase-1 activating adaptor, is downregulated by aberrant methylation in human melanoma. Int J Cancer 2003; 107: 202-8.
27. YOKOYAMA T, SAGARA J, GUAN X et al.: Methylation of ASC/TMS1, a proapoptotic gene responsible for activating procaspase-1, in human colorectal cancer. Cancer Lett 2003; 202: 101-8.
28. RIOJAS MA, GUO M, GLöCKNER SC et al.: Methylation-induced silencing of ASC/TMS1, a pro-apoptotic gene, is a late-stage event in colorectal cancer. Cancer Biol Ther 2007; 6: 1710-6.
29. TERASAWA K, SAGAE S, TOYOTA M et al.: Epigenetic inactivation of TMS1/ASC in ovarian cancer. Clin Cancer Res 2004; 10: 2000-6.
30. STONE AR, BOBO W, BRAT DJ et al.: Aberrant methylation and down-regulation of TMS1/ASC in human glioblastoma. Am J Pathol 2004; 165: 1151-61.
31. COLLARD RL, HARYA NS, MONZON FA et al.: Methylation of the ASC gene promoter is associated with aggressive prostate cancer. Prostate 2006; 66: 687-95.
32. DAS PM, RAMACHANDRAN K, VANWERT J et al.: Methylation mediated silencing of TMS1/ASC gene in prostate cancer. Mol Cancer 2006; 5: 28.
33. OKAMOTO M, LIU W, LUO Y et al.: Constitutively active inflammasome in human melanoma cells mediating autoinflammation via Caspase-1 processing and secretion of interleukin-1. J Biol Chem 2009; 285: 6477-88.
34. LIU W, LUO Y, DUNN JH, NORRIS DA, DINARELLO CA, FUJITA M: Dual role of apoptosis-associated speck-like protein containing a CARD (ASC) in tumorigenesis of human melanoma. J Invest Dermatol 2012; 133: 518-27.
35. SCHIOPPA T, MOORE R, THOMPSON RG et al.: B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis. Proc Natl Acad Sci USA 2011; 108: 10662-7.
36. BRAUMüLLER H, WIEDER T, BRENNER E et al.: T-helper-1-cell cytokines drive cancer into senescence. Nature 2013; 494: 361-5.
37. ZITVOGEL L, KEPP O, KROEMER G: Immune parameters affecting the efficacy of chemotherapeutic regimens. Nat Rev Clin Oncol 2011; 8: 151-60.
38. GHIRINGHELLI F, APETOH L, TESNIERE A et al.: Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β-dependent adaptive immunity against tumors. Nat Med 2009; 15: 1170-8.
39. AYMERIC L, APETOH L, GHIRINGHELLI F et al.: Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity. Cancer Res 2010; 70: 855-8.
40. BRUCHARD M, MIGNOT G, DERANGERE V et al.: Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth. Nat Med 2012; 19: 57-64.
41. Van DEVENTER HW, BURGENTS JE, WU QP et al.: The inflammasome component NLRP3 impairs antitumor vaccine by enhancing the accumulation of tumor-associated myeloidderived suppressor cells. Cancer Res 2010; 70: 10161-9.
42. CONWAY KE, McCONNELL BB, BOWRING CE et al.: TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers. Cancer Res 2000; 60: 6236-42.
43. TSAI H-C, LI H, Van NESTE L et al.: Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells. Cancer Cell 2012; 21: 430-46.
44. RAMACHANDRAN K, GORDIAN E, SINGAL R: 5-azacytidine reverses drug resistance in bladder cancer cells. Anticancer Res 2011; 31: 3757-66.